Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

IAPP boosts islet macrophage IL-1 in type 2 diabetes

A Corrigendum to this article was published on 15 February 2011

This article has been updated

IAPP, a hormone secreted together with insulin and deposited in pancreatic islets in type 2 diabetes, can induce macrophage processing of interleukin 1 linked to beta-cell destruction in type 2 diabetes.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: The beta cell in type 2 diabetes: under fire from friend and foe.

Change history

  • 21 October 2010

    In the version of this article initially published, some of the text on p 882 was inaccurate. The correct text should read as follows: “thereby counteracting the beneficial effects of blocking IAPP on islet inflammation” (middle column) and “This mechanism has been suggested to mediate ROS-dependent inflammasome activation induced by high concentrations of glucose in mouse pancreatic beta cells12, although this finding is now being debated” (right column, first full paragraph, second sentence). The errors have been corrected in the HTML and PDF versions of the article.

References

  1. Kolb, H. & Mandrup-Poulsen, T. Diabetologia 48, 1038–1050 (2005).

    Article  CAS  PubMed  Google Scholar 

  2. Dinarello, C.A. Annu. Rev. Immunol. 27, 519–550 (2009).

    Article  CAS  PubMed  Google Scholar 

  3. Kastner, D.L., Aksentijevich, I. & Goldbach-Mansky, R. Cell; 140, 784–790 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  4. Goldfine, A.B. et al. Ann. Intern. Med. 152, 346–357 (2010).

    Article  PubMed  PubMed Central  Google Scholar 

  5. Larsen, C.M. et al. N. Engl. J. Med. 356, 1517–1526 (2007).

    Article  CAS  PubMed  Google Scholar 

  6. Evans, J.L. et al. Diabetes 52, 1–8 (2003).

    Article  CAS  PubMed  Google Scholar 

  7. Westermark, P. et al. Proc. Natl. Acad. Sci. USA 84, 3881–3885 (1987).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  8. Dinarello, C.A., Donath, M.Y. & Mandrup-Poulsen, T. Curr. Opin. Endocrinol. Diab. (in the press).

  9. Mandrup-Poulsen, T., Pickersgill, L.M.S. & Donath, M.Y. Nat. Rev. Endocrinol. 6, 158–166 (2010).

    Article  CAS  PubMed  Google Scholar 

  10. Masters, S.L. et al. Nat. Immunol. 11, 897–904 (2010).

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Maedler, K. et al. Diabetes 53, 1706–1713 (2004).

    Article  CAS  PubMed  Google Scholar 

  12. Zhou, R. et al. Nat. Immunol. 11, 136–140 (2010).

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Thomas Mandrup-Poulsen.

Ethics declarations

Competing interests

T.M.-P. is a part-time employee of and owns shares in Novo Nordisk.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mandrup-Poulsen, T. IAPP boosts islet macrophage IL-1 in type 2 diabetes. Nat Immunol 11, 881–883 (2010). https://doi.org/10.1038/ni1010-881

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/ni1010-881

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing